At a glance
ClinicalIndex Comparison RecordN/ACompleted· 192 enrolled
Drug / intervention
Placebo +2 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized Non-inferiority Trial of Nano-hydroxyapatite-Containing Toothpastes for Relief of Dentin Hypersensitivity
The University of Texas Health Science Center at San Antonio·interventional·Posted Oct 19, 2020·Updated Aug 16, 2023
In Brief
A clinical study evaluating Placebo, 15% nano-HAP toothpaste, and 1 other intervention for Dentin Sensitivity. Completed, enrolled 192 participants across 1 site.
Detailed Summary
Subjects will be enrolled into 3 balanced groups each using a different strength toothpaste. Dental hypersensitivity (DHS) will be assessed at study start, midway and study end.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDentin Sensitivity
CountriesUnited States
CollaboratorsSangi Co., Ltd.
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartJul 2020
First PostedOct 2020
Primary CompletionFeb 2022
Study CompletionMar 2023
TodayJul 2026
First PostedOct 19, 2020
Enrollment StartJul 28, 2020
Primary CompletionFeb 5, 2022
Study CompletionMar 1, 2023
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 5.7 years ago
Interventions
Placeboother
0% nano-HAP toothpaste
15% nano-HAP toothpastedevice
Toothpaste with identical base formulation as the placebo containing 15% nano-HAP
5% KNO3 toothpastedevice
Toothpaste with identical base formulation as the placebo containing 5% KNO3